)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Evonile Pharma
Evonile Pharma (500672) investor relations material
Evonile Pharma Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary23 Jul, 2026
Executive summary
Q1 FY26/27 revenue from operations was ₹1,038.1 million and profit for the period was ₹322.1 million; both exceeded the year-earlier quarter.
Unaudited results were approved by the Board following Audit Committee review and received a limited review; auditors reported no matters causing them to believe the results contained a material misstatement.
Financial highlights
Revenue from operations was ₹1,038.1 million vs ₹875.5 million YoY; total income was ₹1,125.5 million vs ₹981.6 million.
Total expenses were ₹693.8 million vs ₹609.4 million YoY; profit before tax was ₹431.7 million vs ₹372.2 million.
Profit for the period was ₹322.1 million vs ₹276.2 million YoY; total comprehensive income was ₹322.1 million vs ₹276.2 million.
Other income was ₹87.4 million vs ₹106.1 million YoY; Q1 included no interest on income tax refunds, compared with ₹13.3 million in the prior quarter.
Segment performance
Single operating segment: Pharmaceutical Business, with revenue generated from operations in India.
One customer accounted for ₹532.9 million of revenue from traded goods in Q1, above 10% of total traded-goods revenue; the comparable Q1 prior-year figure was ₹390.4 million.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Evonile Pharma
- H1 profit rose YoY despite weaker Q2 revenue and a 54.0 million tax-litigation provision.500672
Q2 24/25 - Q1 profit rose to ₹257.4 million as revenue reached ₹922.9 million.500672Q1 24/25
- Q3 revenue grew YoY, while profit declined; 9M net profit edged higher.500672Q3 24/25
- FY25 profit and EPS rose despite lower revenue; INR25/share dividend recommended.500672Q4 24/25
- Q1 profit rose YoY despite lower revenue; cost auditor appointment awaits shareholder ratification.500672Q1 25/26
- Q2 profit rose YoY; H1 profit advanced despite lower revenue.500672Q2 25/26
- Q3 revenue and profit fell YoY as Labour Code costs and tax adjustments shaped results.500672Q3 25/26
- FY26 profit declined; a proposed 70.68% stake sale awaits approvals.500672Q4 25/26
Next Evonile Pharma earnings date
Q2 26/273 Nov, 2026
Evonile Pharma
Next Evonile Pharma earnings date
Q2 26/273 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage